Six UK gov­ern­ment com­mit­tees have called for an in­ves­ti­ga­tion in­to the cost of the UK’s phar­ma­ceu­ti­cal trade deal with the US.

The let­ter, pub­lished...

GSK is clos­ing a fac­to­ry in Ger­many and lay­ing off about 650 work­ers as de­mand for egg-based flu vac­cines de­clines, a spokesper­son told End­points News...

Plus more from Reckitt, Astel­las and Hov­ione.

Cel­lares’ first Asian part­ner­ship: The man­u­fac­tur­er has inkeda new part­ner­ship with Tai­wanese com­pa­ny Genome­Fron­tier Ther­a­peu­tics, un­der which...

Schol­ar Rock has won FDA ap­proval for its drug treat­ing a rare mus­cle-wast­ing dis­ease, af­ter fac­ing de­lays due to a trou­bled man­u­fac­tur­ing fac­to­ry.

The in­jectable...

For the first time, No­var­tis’ lead­er­ship in the ra­di­oli­gand field will be test­ed by a gener­ic ri­val.

Curi­um an­nounced on Mon­day that the FDA has...

Cen­tric Com­pound­ing is un­der­go­ing a na­tion­wide re­call of three in­jectable drugs over con­t­a­m­i­na­tion is­sues with an ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API).

Three lots of the Hous­ton-based...

A trade group rep­re­sent­ing gener­ics and biosim­i­lars is warn­ing that the lack of prod­uct de­vel­op­ment could im­per­il bil­lions of dol­lars in po­ten­tial sav­ings.

The new...